SECORA MICHAEL enters IAMBIC THERAPEUTICS, INC. with 190.16K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/14/2026ACC: 0001855980-26-000005
Officer· CFO & Chief Corp Dev Ofcr
Since Oct 2026
190.16K
Baseline shares
100% direct
190.16K
Direct ownership
1 position
261.01K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned190.16K
Total
190.16K direct190.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 190.16K | Direct |
| Total | 190.16K | 190.16K direct |
Derivative Holdings3
Series B-3 Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
61.34K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
190.16K
Shares owned
N/A
Exercise price
7.31
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
9.51K
Shares owned
N/A
Exercise price
8.73
Expiration
—
Exercise window
—
Total
Underlying
261.01K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B-3 Convertible Preferred Stock Direct | Common Stock | — | — | 61.34K | N/A | |
| Employee Stock Option (right to buy) Direct | Common Stock | 7.31 | — | — | 190.16K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 8.73 | — | — | 9.51K | N/A |
| Total | 261.01K | 0.00 | ||||